查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1285897

间质干细胞市场（产品与服务：产品和服务；分离来源：骨髓、脂肪、脐带血、外周血、牙髓及其他） - 2023-2031年全球行业分析、规模、份额、增长、趋势及预测

Mesenchymal Stem Cells Market (Products & Services: Product & Services; Source of Isolation: Bone Marrow, Adipose, Cord Blood, Peripheral Blood, Dental Pulp, & Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 237 Pages | 商品交期: 2-10个工作天内

价格

间充质干细胞市场 - 报告范围

TMR关于全球间质干细胞市场的报告研究了过去以及当前的增长趋势和机会，以获得对2023年至2031年预测期间市场指标的宝贵见解。报告提供了2017-2031年期间全球间质干细胞市场的收入，考虑到2023年为基准年，2031年为预测年。报告还提供了2023年至2031年全球间质干细胞市场的复合年增长率（CAGR %）。

该报告是在广泛的研究后编写的。一级研究涉及大部分的研究工作，其中分析师与关键意见领袖、行业领袖和意见制造者进行了访谈。二级研究包括参考主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解等离子体材料市场。

该报告深入研究了全球等离子体材料市场的竞争格局。在全球间质干细胞市场运作的主要参与者已被确定，其中每一个都在各种属性方面进行了分析。公司概况、财务状况、最近的发展和SWOT是本报告中对全球间质干细胞市场参与者的属性描述。

目录

第一章：前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目标
  • 研究重点

第二章：假设和研究方法

第三章：执行摘要：全球市场

第四章：市场概述

  • 简介
  • 概述
  • 市场动态
    • 驱动力
    • 限制因素
    • 机会
  • 2017-2031年全球市场分析与预测

第五章：关键洞察力

  • 管线分析
  • 参与研究的主要研究机构名单
  • 当前在各种疾病中的趋势和未来前景
  • 各地区/全球的监管情况
  • COVID-19大流行对行业的影响

第六章：全球市场分析和预测：按产品和服务分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 市场价值预测：按产品和服务分类，2017-2031年
    • 产品
      • 工作流程类型
      • 产品类型
    • 服务
  • 市场吸引力分析：按产品和服务分类

第7章 ：全球市场分析和预测：按类型

  • 介绍和定义
  • 主要发现/发展
  • 市场价值预测：按类型，2017-2031年
    • 自体
    • 异源性
  • 市场吸引力分析：按类型划分

第八章：全球市场分析与预测：按分离源分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 市场价值预测：按分离源分类，2017-2031年
    • 骨髓
      • 脂肪
      • 脐带血
      • 周边血
    • 牙髓
    • 其他（肺组织、脐带组织等）。
  • 市场吸引力分析：按分离来源分类

第九章：全球市场分析与预测：按适应症分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 市场价值预测：按适应症分类，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神经系统疾病
    • 自身免疫性疾病
    • 癌症
    • 遗传性疾病
    • 肺部疾病
    • 其他疾病
  • 市场吸引力分析：按适应症

第十章：全球市场分析与预测：按地区划分

  • 主要研究结果
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第11章 ：北美洲市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品和服务，2017-2031年
    • 产品
      • 工作流程类型
      • 产品类型
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 自体
    • 异源性
  • 市场价值预测：按分离来源分类，2017-2031年
    • 骨髓
      • 脂肪
      • 脐带血
      • 周边血
    • 牙髓
    • 其他（肺组织、脐带组织等）。
  • 市场价值预测：按适应症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神经疾病
    • 自身免疫性疾病
    • 癌症
    • 遗传性疾病
    • 肺部疾病
    • 其他疾病
  • 市场价值预测：按国家划分，2017-2031年
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按分离源分类
    • 按适应症分类
    • 按国家分类

第十二章 ：欧洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品和服务，2017-2031年
    • 产品
      • 工作流程类型
      • 产品类型
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 自体
    • 异源性
  • 市场价值预测：按分离来源分类，2017-2031年
    • 骨髓
      • 脂肪
      • 脐带血
      • 周边血
    • 牙髓
    • 其他（肺组织、脐带组织等）。
  • 市场价值预测：按适应症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神经疾病
    • 自身免疫性疾病
    • 癌症
    • 遗传性疾病
    • 肺部疾病
    • 其他疾病
  • 市场价值预测：按国家/次区域，2017-2031年
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按分离源分类
    • 按适应症分类
    • 按国家/次区域分类

第13章 ：亚太地区市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品和服务，2017-2031年
    • 产品
      • 工作流程类型
      • 产品类型
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 自体
    • 异源性
  • 市场价值预测：按分离来源分类，2017-2031年
    • 骨髓
      • 脂肪
      • 脐带血
      • 周边血
    • 牙髓
    • 其他（肺组织、脐带组织等）。
  • 市场价值预测：按适应症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神经疾病
    • 自身免疫性疾病
    • 癌症
    • 遗传性疾病
    • 肺部疾病
    • 其他疾病
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 中国
    • 日本
    • 印度
    • 韩国
    • 亚太其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按隔离源分类
    • 按适应症分类
    • 按国家/次区域分类

第十四章 ：拉美市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品和服务，2017-2031年
    • 产品
      • 工作流程类型
      • 产品类型
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 自体
    • 异源性
  • 市场价值预测：按分离来源分类，2017-2031年
    • 骨髓
      • 脂肪
      • 脐带血
      • 周边血
    • 牙髓
    • 其他（肺组织、脐带组织等）。
  • 市场价值预测：按适应症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神经疾病
    • 自身免疫性疾病
    • 癌症
    • 遗传性疾病
    • 肺部疾病
    • 其他疾病
  • 市场价值预测：按国家/次区域，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按分离源分类
    • 按适应症分类
    • 按国家/次区域分类

第15章 ：中东和非洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品和服务，2017-2031年
    • 产品
      • 工作流程类型
      • 产品类型
    • 服务
  • 市场价值预测：按类型划分，2017-2031年
    • 自体
    • 异源性
  • 市场价值预测：按分离来源分类，2017-2031年
    • 骨髓
      • 脂肪
      • 脐带血
      • 周边血
    • 牙髓
    • 其他（肺组织、脐带组织等）。
  • 市场价值预测：按适应症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神经疾病
    • 自身免疫性疾病
    • 癌症
    • 遗传性疾病
    • 肺部疾病
    • 其他疾病
  • 市场价值预测：按国家/次区域，2017-2031年
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按类型
    • 按隔离源分类
    • 按适应症分类
    • 按国家/次区域分类

第16章 ：竞争格局

  • 市场参与者 - 竞争矩阵（按公司的层级和规模划分）
  • 市场份额分析：按公司划分，2021年
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Cytiva (Danaher Corporation)
    • FUJIFILM Irvine Scientific (FUJIFILM Corporation)
    • Merck KGaA
    • Lonza Group Ltd.
    • STEMCELL Technologies, Inc.
    • Takara Bio, Inc.
    • Sartorius AG
    • Miltenyi Biotec GmbH
    • PromoCell GmbH
Product Code: TMRGL26735

Mesenchymal Stem Cells Market - Scope of Report

TMR's report on the global Mesenchymal Stem Cells Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Mesenchymal Stem Cells Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Mesenchymal Stem Cells Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Mesenchymal Stem Cells market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Mesenchymal Stem Cells market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Mesenchymal Stem Cells market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Mesenchymal Stem Cells market.

The report delves into the competitive landscape of the global Mesenchymal Stem Cells market. Key players operating in the global Mesenchymal Stem Cells Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Mesenchymal Stem Cells Market profiled in this report.

Key Questions Answered in Global Mesenchymal Stem Cells Market Report:

  • What is the sales/revenue generated by Mesenchymal Stem Cells across all regions during the forecast period?
  • What are the opportunities in the global Mesenchymal Stem Cells market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Mesenchymal Stem Cells Market - Research Objectives and Research Approach

The comprehensive report on the global Mesenchymal Stem Cells Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Mesenchymal Stem Cells Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Mesenchymal Stem Cells market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mesenchymal Stem Cells Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Mesenchymal Stem Cells Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List Of Major Research Institutes Involved In Mesenchymal Stem Cells Studies
  • 5.3. Mesenchymal Stem Cells: Current Trends and Future Prospects in a Variety of Disease Conditions
  • 5.4. Regulatory Scenario by Region/globally
  • 5.5. COVID-19 Pandemic Impact on Industry

6. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Products & Services

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Products & Services, 2017-2031
    • 6.3.1. Product
      • 6.3.1.1. Workflow Type
      • 6.3.1.2. Product Type
    • 6.3.2. Services
  • 6.4. Market Attractiveness Analysis, by Products & Services

7. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Type, 2017-2031
    • 7.3.1. Autologous
    • 7.3.2. Allogenic
  • 7.4. Market Attractiveness Analysis, by Type

8. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Source of Isolation

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Source of Isolation, 2017-2031
    • 8.3.1. Bone Marrow
      • 8.3.1.1. Adipose
      • 8.3.1.2. Cord Blood
      • 8.3.1.3. Peripheral Blood
    • 8.3.2. Dental Pulp
    • 8.3.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 8.4. Market Attractiveness Analysis, by Source of Isolation

9. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Musculoskeletal Diseases
    • 9.3.2. Cardiovascular Diseases
    • 9.3.3. Neuro Disorders
    • 9.3.4. Autoimmune Diseases
    • 9.3.5. Cancer
    • 9.3.6. GvHD
    • 9.3.7. Pulmonary Diseases
    • 9.3.8. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Mesenchymal Stem Cells Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Products & Services, 2017-2031
    • 11.2.1. Product
      • 11.2.1.1. Workflow Type
      • 11.2.1.2. Product Type
    • 11.2.2. Services
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Autologous
    • 11.3.2. Allogenic
  • 11.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 11.4.1. Bone Marrow
      • 11.4.1.1. Adipose
      • 11.4.1.2. Cord Blood
      • 11.4.1.3. Peripheral Blood
    • 11.4.2. Dental Pulp
    • 11.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 11.5. Market Value Forecast, by Indication , 2017-2031
    • 11.5.1. Musculoskeletal Diseases
    • 11.5.2. Cardiovascular Diseases
    • 11.5.3. Neuro Disorders
    • 11.5.4. Autoimmune Diseases
    • 11.5.5. Cancer
    • 11.5.6. GvHD
    • 11.5.7. Pulmonary Diseases
    • 11.5.8. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Type
    • 11.7.3. By Source of Isolation
    • 11.7.4. By Indication
    • 11.7.5. By Country

12. Europe Mesenchymal Stem Cells Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Products & Services, 2017-2031
    • 12.2.1. Product
      • 12.2.1.1. Workflow Type
      • 12.2.1.2. Product Type
    • 12.2.2. Services
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Autologous
    • 12.3.2. Allogenic
  • 12.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 12.4.1. Bone Marrow
      • 12.4.1.1. Adipose
      • 12.4.1.2. Cord Blood
      • 12.4.1.3. Peripheral Blood
    • 12.4.2. Dental Pulp
    • 12.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 12.5. Market Value Forecast, by Indication , 2017-2031
    • 12.5.1. Musculoskeletal Diseases
    • 12.5.2. Cardiovascular Diseases
    • 12.5.3. Neuro Disorders
    • 12.5.4. Autoimmune Diseases
    • 12.5.5. Cancer
    • 12.5.6. GvHD
    • 12.5.7. Pulmonary Diseases
    • 12.5.8. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Type
    • 12.7.3. By Source of Isolation
    • 12.7.4. By Indication
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Products & Services, 2017-2031
    • 13.2.1. Product
      • 13.2.1.1. Workflow Type
      • 13.2.1.2. Product Type
    • 13.2.2. Services
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Autologous
    • 13.3.2. Allogenic
  • 13.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 13.4.1. Bone Marrow
      • 13.4.1.1. Adipose
      • 13.4.1.2. Cord Blood
      • 13.4.1.3. Peripheral Blood
    • 13.4.2. Dental Pulp
    • 13.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 13.5. Market Value Forecast, by Indication , 2017-2031
    • 13.5.1. Musculoskeletal Diseases
    • 13.5.2. Cardiovascular Diseases
    • 13.5.3. Neuro Disorders
    • 13.5.4. Autoimmune Diseases
    • 13.5.5. Cancer
    • 13.5.6. GvHD
    • 13.5.7. Pulmonary Diseases
    • 13.5.8. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. South Korea
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Type
    • 13.7.3. By Source of Isolation
    • 13.7.4. By Indication
    • 13.7.5. By Country/Sub-region

14. Latin America Mesenchymal Stem Cells Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Products & Services, 2017-2031
    • 14.2.1. Product
      • 14.2.1.1. Workflow Type
      • 14.2.1.2. Product Type
    • 14.2.2. Services
  • 14.3. Market Value Forecast, by Type, 2017-2031
    • 14.3.1. Autologous
    • 14.3.2. Allogenic
  • 14.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 14.4.1. Bone Marrow
      • 14.4.1.1. Adipose
      • 14.4.1.2. Cord Blood
      • 14.4.1.3. Peripheral Blood
    • 14.4.2. Dental Pulp
    • 14.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 14.5. Market Value Forecast, by Indication , 2017-2031
    • 14.5.1. Musculoskeletal Diseases
    • 14.5.2. Cardiovascular Diseases
    • 14.5.3. Neuro Disorders
    • 14.5.4. Autoimmune Diseases
    • 14.5.5. Cancer
    • 14.5.6. GvHD
    • 14.5.7. Pulmonary Diseases
    • 14.5.8. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Type
    • 14.7.3. By Source of Isolation
    • 14.7.4. By Indication
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Mesenchymal Stem Cells Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Products & Services, 2017-2031
    • 15.2.1. Product
      • 15.2.1.1. Workflow Type
      • 15.2.1.2. Product Type
    • 15.2.2. Services
  • 15.3. Market Value Forecast, by Type, 2017-2031
    • 15.3.1. Autologous
    • 15.3.2. Allogenic
  • 15.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 15.4.1. Bone Marrow
      • 15.4.1.1. Adipose
      • 15.4.1.2. Cord Blood
      • 15.4.1.3. Peripheral Blood
    • 15.4.2. Dental Pulp
    • 15.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Musculoskeletal Diseases
    • 15.5.2. Cardiovascular Diseases
    • 15.5.3. Neuro Disorders
    • 15.5.4. Autoimmune Diseases
    • 15.5.5. Cancer
    • 15.5.6. GvHD
    • 15.5.7. Pulmonary Diseases
    • 15.5.8. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Type
    • 15.7.3. By Source of Isolation
    • 15.7.4. By Indication
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2021
  • 16.3. Company Profiles
    • 16.3.1. Thermo Fisher Scientific, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Cytiva (Danaher Corporation)
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. FUJIFILM Irvine Scientific (FUJIFILM Corporation)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck KGaA
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Lonza Group Ltd.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. STEMCELL Technologies, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Takara Bio, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Sartorius AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Miltenyi Biotec GmbH
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. PromoCell GmbH
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 02: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 03: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 04: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2032
  • Table 05: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 06: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Region, 2017-2032
  • Table 07: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country, 2017-2032
  • Table 08: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 09: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 10: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 11: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 12: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 13: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 14: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 15: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 16: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 17: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 18: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 19: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 20: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 21: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 22: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 23: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 24: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 25: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 26: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 27: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 28: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 29: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 30: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 31: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 32: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 33: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 34: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 35: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 36: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032

List of Figures

  • Figure 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 02: Global Mesenchymal Stem Cells Market Value Share, by Products & Services, 2022
  • Figure 03: Global Mesenchymal Stem Cells Market Value Share, by Type, 2022
  • Figure 04: Global Mesenchymal Stem Cells Market Value Share, by Source of Isolation, 2022
  • Figure 05: Global Mesenchymal Stem Cells Market Value Share, by Indication, 2022
  • Figure 06: Global Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 07: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 08: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Product, 2017-2032
  • Figure 09: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Services, 2017-2032
  • Figure 10: Global Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 11: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 12: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Autologous, 2017-2032
  • Figure 13: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Allogenic, 2017-2032
  • Figure 14: Global Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 15: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 16: Global Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 17: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023-2032
  • Figure 18: Global Mesenchymal Stem Cells Market Value Share Analysis, by Region, 2022 and 2032
  • Figure 19: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Region, 2023-2032
  • Figure 20: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 21: North America Mesenchymal Stem Cells Market Value Share Analysis, by Country, 2022 and 2032
  • Figure 22: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country, 2023-2032
  • Figure 23: North America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 24: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 25: North America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 26: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 27: North America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 28: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 29: North America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 30: North America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 31: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 32: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 33: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 34: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 35: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 36: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 37: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 38: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 39: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 40: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 41: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 42: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 43: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 44: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 45: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 46: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 47: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 48: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 49: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 50: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 51: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 52: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 53: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 54: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 55: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 56: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 57: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 58: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 59: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Type, 2023-2032
  • Figure 60: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 61: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Source of Isolation, 2023-2032
  • Figure 62: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 63: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 64: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 65: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 66: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 67: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 68: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 69: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 70: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 71: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 72: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation, 2023-2032
  • Figure 73: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 74: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023-2032